8-KThe WireRoutine
Bylaw Amendment
Filed Oct 26, 2021 · 4y ago · Accession 0001104659-21-129996
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Xilio Therapeutics, Inc.
- Ticker
- XLO
- CIK
- 1840233
- Form type
- 8-K
- Filing date
- Oct 26, 2021
- Report date
- Oct 26, 2021
- Document
- tm2115750d23_8k.htm
- Size
- 219 KB